| 1 |
27695125 | Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors. | 2016 |
1 |
| 2 |
19666775 | Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitization in airway smooth muscle. | 2009 Oct |
1 |
| 3 |
12834813 | Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7. | 2003 Sep |
1 |
| 4 |
10749688 | Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. | 2000 Apr 15 |
1 |
| 5 |
10779384 | Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity. | 2000 May |
1 |
| 6 |
9720765 | Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors. | 1998 Jun |
1 |
| 7 |
7559525 | Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists. | 1995 Oct 6 |
1 |